Ibuprofen Lyell's Syndrome In An Eight-Year-Old Child

N R Koffi1, Y Pete1, K C N'Da1

  • 1Service d'Anesthésie Réanimation, Centre Hospitalier Universitaire de Bouaké, Côte d'Ivoire.

Insights

Toxic epidermal necrolysis (Lyell's syndrome) is a severe drug reaction requiring intensive care. Early recognition and management are crucial for patient survival and reducing mortality risks.

Area of Science:

  • Dermatology
  • Toxicology
  • Pediatrics

Background:

  • Lyell's syndrome, also known as toxic epidermal necrolysis (TEN), is a rare and severe cutaneous adverse drug reaction.
  • TEN presents as extensive skin and mucous membrane detachment, mimicking severe burns.
  • Urgent and specialized intensive care management is critical for improving patient outcomes.

Purpose of the Study:

  • To report a severe case of Lyell's syndrome in a pediatric patient.
  • To highlight the rapid onset of TEN following self-medication with a common anti-inflammatory drug.
  • To emphasize the importance of prompt diagnosis and management in pediatric TEN.

Main Methods:

  • Case report of an eight-year-old child diagnosed with Lyell's syndrome.
  • Review of clinical presentation, drug history, and treatment course.
  • Focus on the timeline of symptom onset post-medication.

Main Results:

  • The patient developed severe Lyell's syndrome within 24 hours of self-administering ibuprofen.
  • The case underscores the potential severity of common anti-inflammatory drugs in susceptible individuals.
  • Management required intensive care similar to extensive burn treatment.

Conclusions:

  • Lyell's syndrome is a critical medical emergency requiring immediate intervention.
  • Self-medication with over-the-counter drugs like ibuprofen can precipitate severe reactions in children.
  • Vigilance for drug-induced toxic epidermal necrolysis is essential in pediatric practice.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
281
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
172
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
806
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
322
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161